Abiopharma

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Pulmonx to Participate in September Investor Conferences

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

Sana Biotechnology to Present at September 2025 Investor Conferences

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

New Form 8-K - ENSIGN GROUP, INC Filed: 2025-08-26 AccNo: 0001125376-25-000158 Size: 149 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Climer Crystal 🟡 adjusted position in 1.5K shares of Premier, Inc. (PINC) at $25.70 Transaction Date: Aug 22, 2025 | Filing ID: 000006

New Form 8-K - COGNITION THERAPEUTICS INC Filed: 2025-08-26 AccNo: 0001104659-25-083059 Size: 187 KB Item 8.01: Other Events

Director FOEHR MATTHEW W 🟢 acquired 540.5K shares of OmniAb, Inc. (OABI) at $1.85 Transaction Date: Aug 26, 2025 | Filing ID: 000009

Arcturus Therapeutics to Attend Upcoming Investor Conferences

New Form 6-K - SciSparc Ltd. Filed: 2025-08-26 AccNo: 0001213900-25-080737 Size: 12 KB

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025